MET kinase-IN-2
MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM. MET kinase-IN-2 has antitumor activity[1].
Product Specifications
CAS Number
[2101241-90-9]
UNSPSC
12352005
Target
C-Met/HGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/met-kinase-in-2.html
Purity
98.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C(C2=CC=CC=C2)=CNC3=C1C(NC4=CC=C(OC5=CC=NC6=CC(OCC(C)(O)C)=CC=C56)C(F)=C4)=NC=C3
Molecular Formula
C33H27FN4O4
Molecular Weight
562.59
References & Citations
[1]Chen T, et al. Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. Eur J Med Chem. 2020;192:112174.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15139412 1 Vial
Lentiviral mouse Rnf126 shRNA (UAS) - Lentiviral mouseRnf126 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details TDRD7-5661R 50 µg
Recombinant Rat TDRD7 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
K1221903 1.0 µg DNA
LMNL2 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details